Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer.
2021
Background:We previously reported tumor mutation burden (TMB) as a potential prognostic factor for patients with advanced gastric cancer (AGC) receiving immunotherapy. We aimed to comprehensively u...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
1
Citations
NaN
KQI